Table 4 Health facility characteristics and PPH prevention services
From: Postpartum hemorrhage prevention in Nepal: a program assessment
Mountain region | Hill region | Terai region | |
(n = 33) | (n = 33) | (n = 33) | |
Facility level | |||
District hospital or above | 9.1 (3) | 12.1 (4) | 9.1 (3) |
Primary | 6.1 (2) | 9.1 (3) | 9.1 (3) |
Health post | 45.5 (15) | 21.2 (7) | 33.3 (11) |
Sub-health post | 39.4 (13) | 57.6 (19) | 48.5 (16) |
Facility type | |||
CEONC | 0.0 (0) | 6.1 (2) | 6.1 (2) |
BEONC | 9.1 (3) | 6.1 (2) | 6.1 (2) |
Birthing centre | 54.6 (18) | 63.6 (21) | 75.8 (25) |
Non-birthing centre | 36.4 (12) | 24.2 (8) | 12.1 (4) |
Among facilities offering obstetric services a | 21 | 25 | 29 |
AMTSL interventions provided: | |||
Uterotonics | 100.0 (21) | 100.0 (25) | 100.0 (29) |
Controlled cord traction | 98.7 (20) | 100.0 (25) | 100.0 (29) |
Uterine massage | 98.7 (20) | 100.0 (25) | 100.0 (29) |
Type of uterotonics used for PPH preventionb | |||
Oxytocin | 100.0 (75) | 100.0 (75) | 100.0 (75) |
Misoprostol | 19.1 (4) | 56.0 (14) | 10.3 (3) |
Methergine/ergometrine | 23.8 (5) | 32.0 (8) | 17.2 (5) |
Uterotonics currently in stock at facility | |||
Oxytocin | 95.2 (20) | 100.0 (25) | 100.0 (29) |
Misoprostol | 85.7 (18) | 80.0 (20) | 58.6 (17) |
Methergine/ergometrine | 19.1 (4) | 16.0 (4) | 20.7 (6) |
Current stock of uterotonic is sufficient | |||
Oxytocin | 85.7 (18) | 96.0 (24) | 100.0 (29) |
Misoprostol | 57.1 (12) | 56.0 (14) | 41.4 (12) |